Charles River Laboratories International, Inc. CRL
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Elizabeth Anderson | Evercore ISI | 181.18 $ | 200 $ | 18.82 % | 03/10/2025 |
| Luke Sergott | Barclays | 170.48 $ | 195 $ | 24.52 % | 02/10/2025 |
| Luke Sergott | Barclays | 193.14 $ | 205 $ | 11.86 % | 15/10/2024 |
| Jamie Clark | Redburn Partners | 192.97 $ | 151 $ | -41.97 % | 14/10/2024 |
| Ann Hynes | Mizuho Securities | 206.435 $ | 210 $ | 3.57 % | 17/09/2024 |
| Justin Bowers | Deutsche Bank | 200.34 $ | 240 $ | 39.66 % | 08/08/2024 |
| Eric Coldwell | Robert W. Baird | 201.85 $ | 239 $ | 37.15 % | 10/07/2024 |
| Luke Sergott | Barclays | 207.35 $ | 230 $ | 22.65 % | 28/06/2024 |
| Matthew Sykes | Goldman Sachs | 216.12 $ | 290 $ | 73.88 % | 06/06/2024 |
| Elizabeth Anderson | Evercore ISI | 230.09 $ | 265 $ | 34.91 % | 09/05/2024 |
| Elizabeth Anderson | Evercore ISI | 270.95 $ | 300 $ | 29.05 % | 01/04/2024 |
| Donald Hooker | KeyBanc | 257.51 $ | 300 $ | 42.49 % | 05/05/2022 |
| David Windley | Jefferies | 273.03 $ | 280 $ | 6.97 % | 25/04/2022 |
| David Windley | Jefferies | 357.95 $ | 464 $ | 106.05 % | 11/01/2022 |
| David Toung | Argus Research | 377.51 $ | 440 $ | 62.49 % | 24/11/2021 |
| Daniel Brennan | Cowen & Co. | 417.45 $ | 465 $ | 47.55 % | 17/08/2021 |
| Katie Tryhane | Credit Suisse | 416.31 $ | 385 $ | -31.31 % | 04/08/2021 |
| Tycho Peterson | J.P. Morgan | 337.99 $ | 390 $ | 52.01 % | 28/05/2021 |
| Sandy Draper | Guggenheim | 329.52 $ | 369 $ | 39.48 % | 25/05/2021 |